About 4 000 reports

  • Asarina Pharma AB - Key Employees
  • Asarina Pharma AB - Key Competitors

Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB, is a sepranolone product developer.The company offers discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycle linked conditions. It...

  • Healthcare
  • Pharmaceutical
  • Sweden
  • Company
  • Luye Pharma Enters into Licensing Agreement with Lotus Pharma
  • Lotus Pharmaceutical Co Ltd, Subsidiaries

Summary Lotus Pharmaceutical Co Ltd (Lotus Pharmaceutical), a subsidiary of Alvogen Inc is a pharmaceutical company that develops and sells pharmaceutical products.The company provides products that are used in the treatment of rheumatology, cancer, cardiology, dyslipidemia, hypertension, woman healthcare, oncology, gastrointestinal,...

  • Healthcare
  • Pharmaceutical
  • Taiwan
  • Company
  • Alvogen, Inc.
  • Boryung Pharmaceutical Co Ltd - Key Employees
  • Boryung Pharmaceutical Co Ltd, Key Employees

Summary Boryung Pharmaceutical Co Ltd (Boryung), formerly Boryung Drugs Co Ltd is a pharmaceutical company that develops drugs for the treatment of cancer, infections and gene therapy, besides vaccines, other biopharmaceuticals and new chemical entities (NCE).The company provides major products such as Kanarb, a new drug...

  • Healthcare
  • Pharmaceutical
  • South Korea
  • Company
  • Boryung
  • Suda Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Suda Pharmaceuticals Ltd - Key Employees

Summary Suda Pharmaceuticals Ltd (Suda Pharmaceuticals), formerly Suda Ltd is a drug delivery company that offers oro-mucosal administration solutions.The company’s products include SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005, artimist, and zolpimist. Its artimist is a sub-lingual spray for the treatment of p....

  • Pharmaceutical
  • Therapy
  • Australia
  • Company
  • Suda Ltd
  • 2.2 BIG PHARMA FOCUSES ON LABEL EXPANSION, WHILE SMALLER COMPANIES FOCUS ON DEVELOPING DRUGS WITH NOVEL MECHANISMS OF ACTION
  • 8.2 PROMISING DRUGS IN CLINICAL DEVELOPMENT

OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2025 Summary Bladder cancer is a urologic malignancy arising primarily from epithelial cells lining the bladder. In the vast majority of cases (>90%), bladder cancer manifests as transitional (urothelial) cell carcinoma (TCC). The remaining...

  • Pharmaceutical
  • United States
  • Company
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.
  • XERIS Pharmaceuticals Inc - Key Competitors
  • XERIS Pharmaceuticals Inc - Key Employees

Summary XERIS Pharmaceuticals Inc (XERIS) is a pharmaceutical company that develops injectable drugs for the treatment of diabetes, epilepsy and congenital hyperinsulinism.The company provides pipeline products such as Glucagon auto-injectors, multi-dose pens and pumps. It provides G-Pen which is an auto-injectable...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • XERIS Pharmaceuticals, Inc.
  • Asarina Pharma AB, Key Employees
  • Asarina Pharma AB - Key Employees

Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB, is a sepranolone product developer.The company offers discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycle linked conditions. It...

  • Healthcare
  • Pharmaceutical
  • Sweden
  • Company
  • AKCEA THERAPEUTICS INC, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • Akcea Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Akcea Therapeutics Inc (Akcea Therapeutics), a subsidiary of Ionis Pharmaceuticals Inc is a biopharmaceutical company that provides development-stage, advanced, antisense therapies for cardiometabolic lipid disorders. The company’s portfolio drugs are designed based on advanced antisense technology. Its...

  • Pharmaceutical
  • United States
  • World
  • Company
  • Akcea Therapeutics, Inc.
  • Millennium Pharmaceuticals Inc - Key Employees

Summary Millennium Pharmaceuticals Inc (Millennium), a subsidiary of Takeda Pharmaceutical Company Ltd is a biopharmaceutical company that undertakes research, development, and commercialization of drugs for treating cancer.The company’s product Velcade is used for the treatment of multiple myeloma and relapsed mantle cell...

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Millennium
  • Inotek Pharmaceuticals Corp - Key Competitors
  • Inotek Pharmaceuticals Corp - Key Employees

Summary Inotek Pharmaceuticals Corp (IPC) is a pharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of glaucoma and serious diseases of the eye.The company’s trabodenoson is a selective adenosine mimetic that stimulates a specific adenosine subreceptor. Its product pipeline...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Inotek Pharmaceuticals Corporation
  • Britannia Pharmaceuticals Ltd, History
  • Britannia Pharmaceuticals Ltd - Key Employees

Britannia Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Pharmaceutical
  • United Kingdom
  • United States
  • Company
  • Britannia Pharmaceuticals Ltd.

GlobalData Theravectys SA, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Pharmaceutical
  • France
  • United States
  • Company
  • TheraVectys
  • JUL 13, 2017: NIGHTSTAR APPOINTS DAVID LUBNER TO ITS BOARD OF DIRECTORS

GlobalData NightstaRx Ltd' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • United Kingdom
  • United States
  • Company
  • Aridis Pharmaceuticals Inc, Joint Venture
  • Aridis Pharmaceuticals LLC - Key Employees

Summary Aridis Pharmaceuticals LLC (Aridis) is a biotechnology company that utilizes proprietary technologies for producing anti-infectives and vaccines for infectious diseases.The company’s human monoclonal antibody discovery platform technology MabIgX is used for facilitating the development of natural, fully human antibodies...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Aridis Pharmaceuticals LLC
  • Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
  • Amneal Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Amneal Pharmaceuticals LLC (Amneal) is a manufacturer and distributor of generic drugs.The company provides products in the therapeutic areas of anti-anxiety, analgesic, antibiotic, antiepileptic, antihypertensive, anti-inflammatory, cough suppressant, bronchodilator, diuretic, muscle relaxant, vitamin supplement,...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Amneal Pharmaceuticals LLC
  • BEYONDSPRING PHARMA RAISES USD15.3 MILLION IN EQUITY FINANCING
  • BEYONDSPRING INC, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2012 TO YTD 2018

Summary BeyondSpring Pharmaceuticals Inc (BeyondSpring) is a clinical stage biopharmaceutical company that offers development of innovative immune-oncology cancer therapies.The company’s lead compound, Plinabulin, is derived from a natural compound which holds a number of biochemical activities and provides multiple potential...

  • Pharmaceutical
  • China
  • United States
  • Company
  • BeyondSpring Pharmaceuticals Inc.
  • Napp Pharmaceuticals Ltd, History
  • Napp Pharmaceuticals Ltd, Subsidiaries

Napp Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Pharmaceutical
  • Therapy
  • United Kingdom
  • Company
  • Napp Pharmaceuticals Limited
  • Mitobridge Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
  • Mitobridge Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

Summary Mitobridge Inc (Mitobridge), formerly Mitokyne Inc, a subsidiary of Astellas Pharma Inc is a drug development company that discovers and develops small molecule therapeutics that recovers mitochondrial functions.The company develops therapies for rare diseases and expands into more common diseases. Mitobridge...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Mitobridge, Inc.
  • Naia Ltd, Key Competitors
  • PARTNERSHIPS

GlobalData Naia Ltd' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Naia Limited
  • MUNDIPHARMA ENTERS INTO LICENSING AGREEMENT WITH ENDOCEUTICS
  • VERISTAT EXTENDS PARTNERSHIP WITH ENDOCEUTICS

GlobalData Region North America Asia-Pacific Europe Middle East and Africa South and Central America No. of Deals ## ## ## ## NA Deal Value (US$ million) ##. ## NA NA NA NA EndoCeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 ENDO

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • EndoCeutics
  • Complexa Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • VENTURE FINANCING

Summary Complexa Inc (Complexa) is a biopharmaceutical company that develops endogenous human cell signalling treatments for fibrosis and inflammation related diseases.The company’s lead product candidate products includes CXA-10 is an endogenous nitro fatty acid that modulates the human body’s main fibrosis, inflammatory...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Complexa

GlobalData Affinivax Inc' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • Vaccine
  • United States
  • Company
  • Affinivax Inc.
  • Invenra Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Invenra Inc, Key Competitors

Summary Invenra Inc (Invenra) is a biotechnology company that discovers and develops multispecific antibodies for immuno-oncology.The company’s pipeline products include t-cell redirecting b-bodies, OX40 agonist, treg depleter SNIPER and exelixis B-Body. Its B-Body and SNIPER technologies are used to develop novel...

  • Healthcare
  • Monoclonal Antibody
  • Pharmaceutical
  • United States
  • Company

Completed ##-Dec-2014 The Research Institute Lunenfeld-Tanenbaum GlobalData Nurix Inc, Key Competitors Nurix Inc - Key Competitors Nurix Inc - Key Employees Nurix Inc, Key Employees HEAD OFFICE Nurix Inc Suite ## ## Owens Street San Francisco CA ## United States Tel: +## ## ## Fa

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Nurix, Inc.

GlobalData Calimmune Inc, reported one pharmaceuticals & healthcare deal worth $## million in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Calimmune Inc.

Note: Deals include all announced pharmaceuticals & healthcare deals from 2012 onwards, GlobalData Trianni Inc, Deals By Therapy Area, 2012 to YTD 2018 Therapy Area Cardiovascular Infectious Disease Oncology Pharmaceuticals and Healthcare No. of Deals ## ## ##

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • Alector LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • Alector LLC, Key Competitors

Summary Alector LLC (Alector) is a biotechnology company that develops therapies for immune system to cure neurodegeneration and cancer.The company discovers and develops immune modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. It combines state-of-the-art antibody technology and...

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Alector LLC
  • Lycera Corp, Key Competitors
  • Mar 13, 2017: Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors

GlobalData Lycera Corp' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Lycera Corp.

Together, these hospitals handle more than ##, ##, ## patient visits per year, making Florida Hospital one of the nation' s largest nonprofit health systems.

  • Health Services
  • Hospital
  • Pharmaceutical
  • United States
  • Company

The company' s deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • Rebiotix Inc.